|
|
|
Volumn 77, Issue 6, 2002, Pages 295-297
|
|
Trends in neuroprotection.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMLODIPINE;
ANTIPARKINSON AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CANNABINOID;
DOPAMINE RECEPTOR STIMULATING AGENT;
DP-B99;
DRUG DERIVATIVE;
EGTAZIC ACID;
ETHYLENEGLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID BIS(2 OCTYLOXYETHYL) ESTER;
MEMANTINE;
NEUROPROTECTIVE AGENT;
PREGNANE DERIVATIVE;
TIRILAZAD;
AGED;
ANIMAL;
APOPTOSIS;
BRAIN DISEASE;
CLINICAL TRIAL;
EDITORIAL;
EYE DISEASE;
HUMAN;
INTRAOCULAR PRESSURE;
MOUSE;
MULTICENTER STUDY;
OPEN ANGLE GLAUCOMA;
OPTIC NERVE DISEASE;
PATHOPHYSIOLOGY;
PHASE 3 CLINICAL TRIAL;
RAT;
AGED;
AMLODIPINE;
ANIMALS;
ANTIPARKINSON AGENTS;
APOPTOSIS;
BRAIN DISEASES;
CALCIUM CHANNEL BLOCKERS;
CANNABINOIDS;
CLINICAL TRIALS;
CLINICAL TRIALS, PHASE III;
DOPAMINE AGENTS;
EGTAZIC ACID;
EYE DISEASES;
GLAUCOMA, OPEN-ANGLE;
HUMANS;
INTRAOCULAR PRESSURE;
MEMANTINE;
MICE;
MULTICENTER STUDIES;
NEUROPROTECTIVE AGENTS;
OPTIC NERVE DISEASES;
PREGNATRIENES;
RATS;
|
|
EID: 0036593697
PISSN: 03656691
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|
